×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

            

           PROGRAM

 

 

Monday June 8

8.30 Opening remarks

8.35 BTK strategies and best options - session 1

Moderators R. Ferraresi, A. Sauguet, E. Ducasse  
State of the art of BTK-CLI treatment
08.35 Arterial status, angiosome, arterial calcifications, is it possible to plan treatment
at BTK level?
M. Gargiulo
08.43 Big vessel versus small vessel disease: what is the true cause of critical limb ischemia? R. Ferraresi
08.51 BTK long lesions: devices and optimal treatment R. Ferraresi
08.59 Insight about ultrasound in planing, access and control of BTK angioplasty E. Puras Mallagray
09.07 BTK bifurcations: best treatment F. Airoldi
09.20 Drug eluting stent in BTK disease, K. Deloose
09.28 Bare metal stent in BTK disease E. Ducasse
09.36 Drug eluting balloon in BTK disease K. Deloose
09.44 Distal bypass in BTK disease P. Schneider
Tips & tricks & complications
10.30 Challenging BTK case E. Ducasse
10.40 When coronary devices could help? A. Sauguet
10.50 Below-the-ankle angioplasty and stenting for CLI J. Brunet
11.00 Extreme distal revascularization with conventional and alternative techniques M. Di Primio

11.20 Thoracic pathology - session 2

Moderators S. Ronchey, F. Veith  
How I deal with the aortic arch: from planning to follow-up
11.20 My experience in ascending aorta TEVAR I. Loftus
11.28 Open surgery conventional: discrepancy in results (lights and shadow) D. Pacini
11.36 Ascending aorta: is the endovascular approach realistic? T. Kölbel
11.44 Off the shelf solution: selection based on planning N. Mangialardi
11.52 My planing for arch Chimney J. Brunkwall
12.00 Endoleak after arch Chimney R. Kolvenbach
12.08 Hybrid repair: technique for total debranching P. Bergeron, A. Petrosyan
12.16 Stroke rate and mortality in arch procedure M. Lachat
12.24 Endovascular arch repair following ascending aorta open surgery T. Kölbel
12.32 Complications of supraaortic debranching S. Ronchey
12.40 Demonstration (crazy arch case) T. Larzon

14.00 Thoracic pathology - session 3

Moderators J. Busquet, F. Veith, M. Lachat, N. Mangialardi  
Dissection
14.00 We do treat all - and why, N. Cheshire
14.08 I do treat when appropriate, J. Steuer
14.16 The false channel occlusion technique T. Kölbel
14.24 TEVAR for chronic dissection I. Loftus
14.32 News from imaging will change our attitude L. Maene
Descending aorta
14.50 TEVAR European guidelines V. Riambau
14.58 How I fix endoleak in TEVAR P. Kasprzak
15.06 Clampless sutured anastomosis technique Z. Rancic
15.14 Long-term results for TEVAR after BAI R. Vallabhaneni
15.22 Access vessels challenges and best access route F. Setacci
     

15.45 : Highly complex lesions in femo/pop. What do I learn from my daily practice? - session 4

15.45 Clinical case review J. Brunet
15.57 Clinical case review M. Amor
     

16.45 Femoropopliteal disease - Part 1 - session 5

Moderators Y. Gouëffic, K. Deloose, P. Schneider, C. Setacci  
Strategy
16.45 Anti-platelet therapy: who needs it and what to prescribe K. Deloose
16.53 Popliteal artery aneurysm - What is the best mode of treatment? T. Schmitz Rixen
17.01 Radial access for femoropopliteal lesions: tips and tricks R. Coscas
17.09 Closure devices: treatment of complications J. Van den berg
TASC A/B femoropopliteal lesions
17.20 Is connected stent the good option for TASC A/B SFA lesions? E. Ducasse
  Debate. TASC A/B femoropopliteal lesions treatment  
17.35 Stent should be the first line treatment J-P. de Vries
17.43 Two-year results of a low-dose drug-coated balloon for revascularization of the
femoropopliteal artery (ILLUMENATE FIH Trial)
Y. Gouëffic
17.51 DES should be the first line treatment J. Van Den Berg
18.05 Are current stents ready for the « surgical landing-zones »? L. Maene
18.13 Lecture from China: Selective stent placement versus balloon angioplasty for
renovascular hypertension caused by Takayasu Arteritis: two-year results
X. Jiang

 

Tuesday June 9

08.15 Carotid Occlusive Disease - Are we ready for the next breakthrough? - session 6

Moderators M. Amor, P. Schneider, K. Snyder, L. Inglese  
08.15 State-of-the-art: promising next steps K. Mathias
08.30 What the data is telling us: the first 30 days need to be safer after any carotid repair,
but how?
C. Setacci
08.38 New stent designs: will they improve results? P. Schneider
08.46 New access technologies N. Cheshire
Controversy
08.54 Best medical therapy has improved: but how much, and will BMT be good
enough to replace repair?
I. Van Herzeele
08.59 Carotid endarterectomy remains the treatment of choice. The data prove it
and stents cannot compete
A. Mansilha
09.09 What is the optimal approach to asymptomatic carotid stenosis? Intervention or not?
We cannot all be correct!
A. Halliday
09.17 Challenging case: the worst complication of the year. Can you help me problem
solve?
M. Amor
09.25 Selection of stent and protection technique: which stent for which lesion M. Amor
09.33 Emergency management system: how to handle evolving stroke K. Mathias
09.41 Mechanical thrombectomy for acute stroke K. Snyder
 
10.30 Results from the ROADSTER Trial and EU Experience I. Van Herzeele
10.38 CAS revival is now P. Bergeron
10.46 Get organized for in Hospital stroke (jatrogenic or not) acute rescue L. Inglese
11.00  How I see the future of CAS F. Veith

11.15 Femoropopliteal disease - Part 2 - session 7

Moderators Y. Gouëffic, K. Deloose, P. Schneider, C. Setacci  
TASC C/D femoropopliteal lesions
11.15 Heparin bounded graft could challenge endovascular repair for TASC C-D lesions? R. Pulli
11.23 Intra versus subintimal routes to treat femoropopliteal CTO lesions: techniques and results F. Thaveau
11.31 Endovascular treatment of occluded popliteal artery aneurysm P. Veroux
Managing complications
11.45 How should we manage acute in-stent thrombosis during femoropopliteal recanalisation? Y. Gouëffic
11.53 Recurring in-stent restenosis: what is the best management?

E. Ducasse

12.01 Acute popliteal endograft occlusion: frequency and management E. Puras Mallagray
     

12.15 Next generation drug eluting technologies - session 8

12.15 Clinical results Majestic trial K. Keirse
12.35 Experience of drug eluting technologies M. Sibé
     

14.00 The A-Z of A-I disease - session 9

Moderators R. McWilliams, I. Van Herzeele  
Access
14.00 How I do PEVAR? – Video Z. Rancic
Imaging
14.08 Overlay and dose reduction during aortic procedures J. Constantinou
AAA    
14.16 Will EVAS replace EVAR? I. Loftus
14.24 EVAS and EVAR: What are the differences in case selection, deployment and surveillance? F. Torella
14.32 Single sided access for EVAR: the future M. Lachat
14.40 Review of the literature on type II endoleaks R. McWilliams
14.48 Late endoleak management – case discussions – MCQ’s J. Van Den Berg
14.56 State of the art – How I do FEVAR? P. Kasprzak
15.04 Troubleshooting after FEVAR R. Vallabhaneni
15.12 Iliac branched devices versus Iliac branched endoprothesis – differences in selection and usage F. Verzini
15.20 The lessons I have learned from RCT on RAAA management F. Veith
15.28 New evidences for hypogastric artery preservation during EVAR E. Jean-Baptiste
15.36 Tips and tricks for the CERAB technique K. Deloose
15.44 Is the endovascular world ready for 3D-printing and... vice versa? L. Maene

 

Monday June 8th

8.30 Opening remarks

8.35 BTK strategies and best options - session 1

Moderators: R. Ferraresi, A. Sauguet, E. Ducasse
State of the art of BTK-CLI treatment


08.35 Arterial status, angiosome, arterial calcifications, is it possible to plan treatment at BTK level? M. Gargiulo
08.43 Big vessel versus small vessel disease: what is the true cause of critical limb ischemia? R. Ferraresi
08.51 BTK long lesions: devices and optimal treatment R. Ferraresi
08.59 Insight about ultrasound in planing, access and control of BTK angioplasty E. Puras
09.07 BTK long lesions: devices and optimal treatment F. Airoldi
09.20 Drug eluting stent in BTK disease K. Deloose
09.28 Bare metal stent in BTK disease E. Ducasse
09.36 Drug eluting balloon in BTK disease K. Deloose
09.44 Distal bypass in BTK disease P. Schneider

Tips & tricks & complications
10.30 Challenging BTK case E. Ducasse
10.40 When coronary devices could help? A. Sauguet
 

10.45 To close or not to close?

Animator: K. Deloose
Is it still a question (for large access)? S. Haulon

11.15 TAA - Part 1

Debate
11.15 - There is no U-turn for the endovascular treatments, F. Pecoraro

Hot Topics
11.36 - Scallop-graft for the arch repair, my experience, J-M. Alsac
11.44 - Chimps and regular are still a valuable option for arch repair, S. Ronchey


Tips and Tricks
11.57 - fEVAR and branch graft for aortic dissection repair, S. Haulon
12.05 - Aortic dissection: where is the important focus during rst days/weeks? N. Cheshire
12.13 - Endovascular management (petticoat technique) for the type B dissection, L. Canaud
12.21 - Tevar is the first line treatment S.Ronchey
12.29 - Hybrid repair for aortic dissection, indication and state of the art, F. Pecoraro
12.37 - News from imaging and 3D-printing for aortic dissection comprehension, L. Maene

14.00 TAA - Part 2

Animator: B. Mees
Moderators: L. Canaud, N. Mangialardi, F. Pecoraro

Real world TAA Case Extravaganza
14.00 - How would you treat it? Challenging scenarios that stump the experts, L. Canaud
Points of interest
14.08 - Real incidences of endoleaks after TEVAR, R. McWilliams

14.20 AAA

Animator: K. Deloose
Moderators: E. Jean-Baptiste, B. Mees, N. Mosquera
Debate
14.20 - Are we pushing too far the frontiers of EVAR? E. Steinmetz
14.28 - There are no limits using EVAR for AAA! F. Noya

Hot Topics
14.36 - Best practice in fEVAR in 2016, B. Mees
14.44 - EVAS and chEVAS will replace EVAR and chEVAR, F. Torella
14.52 - Chimps and regular devices are still a valuable option, F. Pecoraro
15.00 - Ultra low profile device: behind the boundaries! X. Bérard


Tips and Tricks
15.08 - Management of the hypogastric artery during EVAR, F. Torella
15.16 - Perfect proximal anchorage. Does it solve all the problems? J-P. de Vries
15.24 - Management of challenging iliac accesses and leg thrombosis prevention, A Mansilha
15.32 - The usage of covered balloon expandable stent in Ch-EVAR/S procedures, J-P. de Vries
15.40 - Physician-made versus regular fenestration, is there a difference? E. Ducasse


Real World AAA Case Extravaganza
15.56 - How would you treat it? Challenging scenarios that stump the experts, B. Mees, T. Larzon

Points of Interest
16.12 - How to deal with type 1 endoleaks? N. Cheshire
16.20 - Diagnosis and management of type 3b endoleak, R. McWilliams
16.28 - Sorry to curb the enthusiasm, but how to treat the infected endografts? X. Berard

17.30 Venous & thrombectomy

Moderators: S. Chastanet, P. Pittaluga

17.30 Would you treat it? Challenging scenarios that stump the expert. B.Mees
17.30 What might bring a new wave length for endovenous laser? L. Kabnick
17.40 Should we really treat varicose tributaries? S. Onida
18.00 Hemodynamics of development of the varicose disease: do we really have a new knowledge? S. Onida
18.10 Endovenous treatment of the short saphenous vein: as good as for the great saphenous vein? P. Nicolini
18.20 Endovascular treatment of extended iliac vein occlusion: what are the limits? A. Davies
18.30 What will be the treatment of varicose veins in the future? R. Milleret
18.40 Management strategies for patients with varicose veins (C2-C6): results of a worldwide survey, A. Davies

Friday June 3rd

08.15 Modern approach of carotid artery disease

Animator: P. Schneider
Moderator: M. Amor, I. Van Herzeele

Debate
08.15 Key articles from the past year that will influence carotid artery disease treatment going forward, I. Van Herzeele
08.23 - Urgent repair of carotid disease causing stroke means it should be done within 48 hours, A. Mansilha
08.31 - Urgent repair after stroke has a higher perioperative risk and I never do it in the first two weeks, N. Hopkins


Hot Topics
08.50 - If you want to prove that your outcomes are excellent, then perform DW-MRI in all CEA and CAS patients, I. Van Herzeele

Tips and Tricks
09.00 - Troubleshooting during carotid endarterectomy, C. Setacci
09.08 - Ideal toolkit for carotid stenting. How to customize your approach for different types of cases, M. Amor


Real World AAA Case Extravaganza
09.30 - How would you treat it? Challenging scenarios that stump the experts, N. Hopkins, P. Montorsi
09.50 - Future of carotid revascularization (include Mesh covered stents, prox protection, new designs, transcervical), P. Schneider
10.00 - Standard operating protocol in stroke management at my hospital – a multidisciplinary approach is mandatory, A. Halliday
10.08 New micromesh carotid stent, M. Amor

11.00 Venous & thrombectomy

Animator: R. Milleret, P. Nicolini

 

12.00 How BMS and POBA history?

Moderators: Y. Gouëffic, K. Deloose
The usage of DET in my practice, J. Sobocinski, G. Goyault

13.30 Femoropopliteal disease & Ambulatory

Endovascular repair for long femoropopliteal lesions
Animator: K. Deloose
Moderators: Y. Gouëffic, J. Lemoine

13.30 State of art, P. Schneider
13.40 Missing data, G. Torsello

Real world
14.00 - Long FP lesions with supera, L. Maene
14.10 - Long FP lesions with laser, E. Ducasse
14.20 - Long FP lesions with reentry/pedal access, M. Di Primio

 

14.50 Ambulatory management for PAD endovascular treatment

Animators: E. Steinmetz
Moderator: L. Maene, G. Torsello

14.50 State of art, P. Schneider
15.00 Missing data, F. Airoldi
15.20 Real life, Y. Gouëffic

Debate
15.30 - For 4F devices with 0.018, O. Regnard
15.40 - For 5F devices with 0.035, F. Airoldi
16.10 - Outpatients management is profitable, Y. Gouëffi

16.30 Associate Faculty Program

18.00 Awards ceremony & Adjournment

 


MEET 2015 - Session 4

Highly complex lesions in femo/pop. What do I learn from my daily practice?

Share

MEET 2015 - Session 6

Carotid Occlusive Disease - Are we ready for the next breakthrough?

Share

MEET 2015 - Session 8

Next generation drug eluting technologies

Share
Scroll Up